Search Results - Daniel Molin

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival by Josefine Lundberg, David Berglund, Daniel Molin, Amelie Kinch

    Published in Upsala Journal of Medical Sciences (2019-04-01)
    Get full text
    Article


  2. 2

    Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival – a Swedish Lymphoma Register Study by Sara Ekberg, Daniel Molin, Simon Pahnke, Fanny Bergström, Elsa Brånvall, Karin E. Smedby, Tove Wästerlid

    Published in Acta Oncologica (2024-04-01)
    Get full text
    Article


  3. 3

    High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors? by Anne Andersson, Gunilla Enblad, Martin Erlanson, Ann-Sofie Johansson, Daniel Molin, Björn Tavelin, Ulf Näslund, Beatrice Melin

    Published in Upsala Journal of Medical Sciences (2021-02-01)
    Get full text
    Article


  4. 4

    P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma. by Johan Linderoth, Eva Freyhult, Ellinor Andreasson, Ann-Sofie Johansson, Anne Andersson, Ingrid Glimelius, Gunilla Enblad, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  5. 5

    P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma by Johan Mattsson Ulfstedt, Eva Freyhult, Christina Christersson, Charlott Mörth, Masood Kamali-Moghaddam, Anna Eriksson, Gunilla Enblad, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  6. 6

    Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors by Sambit Tarai, Elin Lundström, Therese Sjöholm, Hanna Jönsson, Alexander Korenyushkin, Nouman Ahmad, Mette A. Pedersen, Daniel Molin, Gunilla Enblad, Robin Strand, Håkan Ahlström, Joel Kullberg

    Published in Heliyon (2024-02-01)
    Get full text
    Article


  7. 7

    High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome by Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Mortensen, Rose-Marie Amini, Stephen Hamilton-Dutoit, Francesco d'Amore, Daniel Molin, Ingrid Glimelius

    Published in Blood Advances (2017-08-01)
    Get full text
    Article


  8. 8

    Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years by Björn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Ingemar Lagerlöf, Ann‐Sofie Johansson, Marzia Palma, Lotta Hansson, Johan Linderoth, Christina Goldkuhl, Daniel Molin

    Published in eJHaem (2021-08-01)
    Get full text
    Article


  9. 9

    Congestive heart failure after anthracycline‐containing treatment for Hodgkin lymphoma: A Swedish matched cohort study by Joachim Baech, Tarec Christoffer El‐Galaly, Joshua P. Entrop, Ingrid Glimelius, Daniel Molin, Sissel Johanne Godtfredsen, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Dietrich

    Published in eJHaem (2024-12-01)
    Get full text
    Article


  10. 10

    P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival by Joachim Baech, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly, Daniel Molin, Ingrid Glimelius, Joshua P. Entrop, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Weibull

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  11. 11

    Response to Comment on: A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma by Kjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, Bente L. Wold, Ninja Övergaard, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Daniel Molin, Alexander Fosså

    Published in Haematologica (2025-06-01)
    Get full text
    Article


  12. 12

    A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma by Kjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, Bente L. Wold, Ninja Övergaard, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Daniel Molin, Alexander Fosså

    Published in Haematologica (2025-04-01)
    Get full text
    Article


  13. 13

    T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients by Ninja Övergaard, Kjersti Lia, Peter Asdahl, Per Wikman, Ingrid Glimelius, Ingemar Lagerlöf., Ann-Sofie Johansson, Lotta Hansson, Gunilla Enblad, Johan Linderoth, Christina Goldkuhl, Alexander Fosså, Peter Kamper, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  14. 14

    Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma by Heli Vajavaara, Frida Ekeblad, Harald Holte, Judit Jorgensen, Suvi-Katri Leivonen, Mattias Berglund, Peter Kamper, Holger J. Moller, Francesco d’Amore, Daniel Molin, Gunilla Enblad, Maja Ludvigsen, Ingrid Glimelius, Sirpa Leppa

    Published in Haematologica (2021-03-01)
    Get full text
    Article


  15. 15

    Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the pros... by Alexander Fosså, Daniel Molin, Paul J. Bröckelmann, Gundolf Schneider, Ulf Schnetzke, Johan Linderoth, Peter M. H. Kamper, Sirpa M. Leppä, Julia Meissner, Valdete Schaub, Kjersti Lia, Michael Fuchs, Peter Borchmann, Boris Böll

    Published in HemaSphere (2025-03-01)
    Get full text
    Article


  16. 16

    P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients by Christina Goldkuhl, Alexandru Dasu, Anna Bäck, Gunilla Enblad, Ingrid Glimelius, Annika Hall, Lotta Hansson, Urban Jerlström., Ann-Sofie Johansson, Jenny Kahlmeter-Brandell, Johan Linderoth, Marzia Palma, Hillevi Rylander, Marika Enmark, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  17. 17

    T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway by Joshua P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. øvlisen, Daniel Molin, Ingrid Glimelius, Anna Marklund, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer El-Galaly, Sandra Eloranta

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  18. 18

    Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Stefano Luminari, Daniel Molin, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella

    Published in Blood Cancer Journal (2025-10-01)
    Get full text
    Article


  19. 19

    Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients by Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H. Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A. Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså

    Published in HemaSphere (2025-08-01)
    Get full text
    Article


  20. 20

    The National Swedish Lymphoma Register – a systematic validation of data quality by Karin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, Victor Falini, Urban Jerlström, Fredrik Ellin, Karin Papworth, Johanna Westerberg, Catharina Lewerin, Per-Ola Andersson, Hallgerdur Lind Kristjansdottir, Lena Brandefors, Charlott Mörth, Karin Hallén, Nevzeta Kuric, Amal Abu Sabaa, Björn E. Wahlin, Daniel Molin, Gunilla Enblad, Ann-Sofi Hörstedt, Mats Jerkeman, Ingrid Glimelius

    Published in Acta Oncologica (2024-07-01)
    Get full text
    Article


Search Tools: